CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, announced the launch of its new line of bioinks for 3D bioprinting. The new bioinks are designed to be biocompatible and versatile, making them ideal for a wide range of applications, including 3D biological model construction and cultivation, tissue engineering, and drug delivery.
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has introduced its new qPCR Assay to the research community for virus detection and quantification, gene expression analysis, relative/absolute quantification, mutation analysis, and genotyping.
CloudLIMS to showcase its configurable, secure, in-the-cloud Clinical LIMS at booth 4089 during the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo.
This partnership marks the world’s first LIMS-integrated solution that fosters trust and transparency in human materials scientific research by allowing research participants to track and trace, and benefit from, the use of their samples and data.
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently launched its new Time-Lapse Imaging services to assist scientists in a variety of projects, including the study of cell migration in chemotaxis assays or wound healing assays, the identification of stem cells and embryos and their development, and the measurement of cell proliferation over time.
STEMart, a US-based provider of comprehensive services for all phases of medical device development, is pleased to announce that it offers Disinfection Validation Services for reusable medical devices. These services are designed to ensure that products meet FDA requirements for disinfection validation and patient safety.
Satisfied Users & 
Approved Press Releases
